Novartis announced the company’s financial results for the second quarter and first half of 2021.
As the world population nears the 8 billion mark, Novartis is celebrating the delivery of 1 billion antimalarial treatments since 1999. That is the equivalent of 1 in 8 people living on our planet!
Novartis is committed to transforming the lives of people living with blood cancers and serious blood disorders.
With a breakthrough approval 20 years ago, Novartis opened the door to reimagine CML and other cancers. The pursuit of bold science didn’t stop there.
Understanding asthma: What are your misconceptions? This World Asthma Day find out more about asthma and challenge your misconceptions.
Ad hoc announcement pursuant to article 53 Listing Rules.
Learn More
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.
